BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11781628)

  • 1. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
    Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P
    Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMV-antigenemia after allogeneic bone marrow transplantation: correlation of CMV-antigen positive cell numbers with transplant-related mortality.
    Bacigalupo A; Tedone E; Isaza A; Soracco M; Van Lint MT; Sanna A; Frassoni F; Occhini D; Gualandi F; Lamparelli T
    Bone Marrow Transplant; 1995 Jul; 16(1):155-61. PubMed ID: 7581116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of cytomegalovirus after bone marrow transplantation by polymerase chain reaction, virus culture and antigen detection in buffy coat leukocytes.
    Schmidt CA; Oettle H; Wilborn F; Jessen J; Timm H; Schwerdtfeger R; Oertel J; Siegert W
    Bone Marrow Transplant; 1994 Jan; 13(1):71-5. PubMed ID: 8019456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT.
    Ljungman P; De Bock R; Cordonnier C; Einsele H; Engelhard D; Grundy J; Locasciulli A; Reusser P; Ribaud P
    Bone Marrow Transplant; 1993 Oct; 12(4):399-403. PubMed ID: 8275040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients.
    Vlieger AM; Boland GJ; Jiwa NM; de Weger RA; Willemze R; de Gast GC; Falkenburg JH
    Bone Marrow Transplant; 1992 Apr; 9(4):247-53. PubMed ID: 1318141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of active cytomegalovirus infection by analysis of immediate-early, early and late transcripts in peripheral blood cells of immunodeficient patients.
    Meyer T; Reischl U; Wolf H; Schüller C; Arndt R
    Mol Cell Probes; 1994 Aug; 8(4):261-71. PubMed ID: 7870068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy.
    Mandanas RA; Saez RA; Selby GB; Confer DL
    Am J Hematol; 1996 Feb; 51(2):104-11. PubMed ID: 8579049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abortive human cytomegalovirus infection in patients after allogeneic bone marrow transplantation.
    de Gast GC; Boland GJ; Vlieger AM; de Weger RA; Verdonck LF; Zwaan FE; Jiwa NM
    Bone Marrow Transplant; 1992 Apr; 9(4):221-5. PubMed ID: 1318140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients.
    Brytting M; Mousavi-Jazi M; Boström L; Larsson M; Lunderberg J; Ljungman P; Ringdén O; Sundqvist VA
    Transplantation; 1995 Nov; 60(9):961-5. PubMed ID: 7491701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality.
    Bacigalupo A; Tedone E; Sanna MA; Moro F; Van Lint MT; Grazi G; Balestreri M; Frassoni F; Occhini D; Gualandi F
    Haematologica; 1992; 77(6):507-13. PubMed ID: 1337746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and practical value of human cytomegalovirus DNAemia detection by semi-nested PCR for follow-up of BMT recipients.
    Imbert-Marcille BM; Milpied N; Coste-Burel M; Richet B; Moreau P; Harousseau JL; Billaudel S
    Bone Marrow Transplant; 1995 Apr; 15(4):611-7. PubMed ID: 7655389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three weeks of ganciclovir for cytomegaloviraemia after allogeneic bone marrow transplantation.
    Singhal S; Mehta J; Powles R; Treleaven J; Horton C; Carrington D; Tryhorn Y; Jameson B
    Bone Marrow Transplant; 1995 May; 15(5):777-81. PubMed ID: 7670405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of cytomegalovirus: methodologic aspects and clinical applications.
    Boeckh M; Boivin G
    Clin Microbiol Rev; 1998 Jul; 11(3):533-54. PubMed ID: 9665982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute cytomegalovirus gastritis after kidney transplantation. Its diagnosis by the polymerase chain reaction, antigenemia assay and immunohistochemistry].
    Stenglein S; Werner M; Sinzger C; Korn K; Plachter B; Beck R; Neumayer HH; Jahn G
    Dtsch Med Wochenschr; 1993 Nov; 118(44):1597-602. PubMed ID: 8223213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of target organ infection with cytomegalovirus in the pathogenesis of graft-versus-host disease.
    Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Proctor SJ; Hamilton PJ; Cant AJ
    Bone Marrow Transplant; 1995 Apr; 15(4):557-61. PubMed ID: 7655381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients.
    Lautenschlager I; Höckerstedt K; Salmela K
    Transplant Proc; 1994 Jun; 26(3):1719-20. PubMed ID: 8030100
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
    Iberer F; Halwachs-Baumann G; Rödl S; Pleisnitzer A; Wasler A; Auer T; Petutschnigg B; Müller H; Tscheliessnigg K; Wilders-Truschnig M
    J Heart Lung Transplant; 1994; 13(3):405-11. PubMed ID: 8061015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin).
    Zintl F; Färber I; Hermann J; Fuchs D; Prager J; Wutzler P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):557-64. PubMed ID: 2480308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The antigenemia test for cytomegalovirus].
    Pérez JL; Salvà J; Niubó J
    Enferm Infecc Microbiol Clin; 1994 May; 12(5):251-61. PubMed ID: 8049289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.